V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260010091 | 260006381 | null | 90.4 | Neo-adjuvant (N) | 2019-06-03 | 2019-06-03 | Temozolomide + RT | 2 | N | 260019716 | CISPLATIN + IFOSFAMIDE + VINBLASTINE |
| 260010092 | 260006381 | 1.68 | 67.2 | Curative (C) | 2016-12-06 | 2017-04-25 | Rituximab | N | N | 260019716 | CISPLATIN + ETOPOSIDE |
| 260010093 | 260006381 | 1.68 | 79.1 | Curative (C) | 2017-11-10 | 2017-11-27 | Trial Unspecified | N | N | 260019716 | HYDROXYCARBAMIDE |
| 260010094 | 260006382 | 1.72 | 77.1 | Curative (C) | 2015-06-04 | 2015-06-11 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260019845 | ACE (GERM CELL) |
| 260010095 | 260006382 | 1.75 | null | null | 2013-07-14 | 2013-07-28 | BLEOMYCIN + VINCRISTINE | N | N | 260019845 | ETOPOSIDE |
| 260010096 | 260006382 | 1.67 | 76.7 | Palliative (P) | 2017-02-11 | 2017-02-13 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | N | 260019845 | ETOPOSIDE |
| 260010097 | 260006382 | 1.62 | 64 | Disease modification (D) | 2018-09-18 | 2018-09-20 | Rituximab | 99 | N | 260019845 | HYDROXYCARBAMIDE |
| 260010098 | 260006382 | 1.6 | 64 | Curative (C) | 2013-09-09 | 2013-10-07 | Cisplatin + Etoposide (5 day) | N | N | 260019845 | CISPLATIN + ETOPOSIDE |
| 260010099 | 260006382 | 1.8 | null | Palliative (P) | 2017-08-28 | 2018-09-01 | Cisplatin + Etoposide (5 day) | N | N | 260019845 | CISPLATIN + ETOPOSIDE |
| 260010100 | 260006383 | 1.62 | 76.6 | Palliative (P) | 2018-06-20 | 2018-06-24 | Rituximab (Maintenance) | 02 | N | 260020117 | SUNITINIB |
| 260010101 | 260006383 | null | 92 | Curative (C) | 2018-10-07 | 2018-10-07 | Carboplatin + Pemetrexed | 99 | null | 260020117 | TRIAL |
| 260010102 | 260006383 | 1.8 | null | Curative (C) | 2015-06-17 | 2015-06-17 | EP | N | N | 260020117 | CARBOPLATIN + ETOPOSIDE |
| 260010103 | 260006384 | 1.88 | 74.5 | Curative (C) | 2016-12-24 | 2016-12-25 | Carboplatin + Etoposide IV 3 day | 2 | null | 260020256 | NOT MATCHED |
| 260010104 | 260012476 | 1.66 | 69 | Unknown (U) | 2016-04-07 | 2016-05-03 | Rituximab | 2 | N | 260020285 | RITUXIMAB |
| 260010105 | 260006385 | 1.62 | null | Curative (C) | 2017-05-08 | 2017-05-31 | Cisplatin + Pemetrexed | N | Y | 260020389 | CISPLATIN + ETOPOSIDE |
| 260010106 | 260006385 | 1.64 | 62 | Curative (C) | 2017-11-06 | 2017-11-06 | Rituximab | 2 | N | 260020389 | CISPLATIN + PEMETREXED |
| 260010107 | 260006386 | 1.78 | 72.3 | null | null | 2016-08-23 | Trial Unspecified | null | null | 260020437 | IVA |
| 260010108 | 260006386 | 1.64 | 65 | Curative (C) | 2013-07-08 | 2013-07-09 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260020437 | ETOPOSIDE + RITUXIMAB |
| 260010109 | 260006387 | 1.74 | 0 | Palliative (P) | null | 2015-02-03 | Cisplatin + Etoposide (5 day) | null | null | 260020478 | CISPLATIN + ETOPOSIDE |
| 260010110 | 260006387 | 1.75 | 74 | Palliative (P) | 2016-05-30 | 2016-06-01 | Cisplatin + Etoposide (5 day) | N | N | 260020478 | CISPLATIN + ETOPOSIDE |
| 260010111 | 260015744 | 1.77 | 92 | Palliative (P) | 2016-11-30 | 2016-12-31 | ETOPOSIDE | N | N | 260020774 | CISPLATIN + ETOPOSIDE |
| 260010112 | 260006388 | 1.76 | 80 | Curative (C) | 2015-02-10 | 2015-02-15 | Carboplatin + Etoposide IV 3 day | N | N | 260020778 | IVA |
| 260010113 | 260006388 | 1.88 | 94.3 | Palliative (P) | 2015-12-13 | 2015-12-18 | Bendamustine +/- Prednisolone | N | N | 260020778 | CISPLATIN + ETOPOSIDE |
| 260010114 | 260006389 | null | 107.4 | Palliative (P) | 2015-11-23 | 2015-12-01 | 111 Trial (formerly BEP 111) | N | N | 260021385 | CISPLATIN + ETOPOSIDE |
| 260010115 | 260006389 | 1.79 | 103 | Palliative (P) | 2015-06-06 | 2015-06-07 | Cisplatin + Etoposide (5 day) | N | N | 260021385 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260010116 | 260006390 | 1.55 | 65.4 | Curative (C) | 2017-03-10 | 2017-03-23 | R Chlorambucil | 2 | N | 260021538 | CISPLATIN |
| 260010117 | 260012482 | 1.48 | 75 | Palliative (P) | 2015-09-17 | 2015-09-22 | Rituximab | null | null | 260021620 | CISPLATIN |
| 260010118 | 260012482 | 1.81 | 101 | Disease modification (D) | 2015-10-01 | 2015-10-02 | 111 Trial (formerly BEP 111) | 2 | N | 260021620 | CARBOPLATIN + PACLITAXEL |
| 260010119 | 260012482 | 1.6 | 82.8 | Palliative (P) | 2019-02-18 | 2019-02-18 | ETOPOSIDE | 02 | N | 260021620 | BENDAMUSTINE |
| 260010120 | 260012482 | 1.62 | null | Neo-adjuvant (N) | 2017-09-30 | 2017-10-03 | PACLITAXEL | 2 | N | 260021620 | PACLITAXEL |
| 260010121 | 260018901 | 1.81 | 90.9 | Disease modification (D) | 2014-09-07 | 2014-12-07 | BLEOMYCIN + CISPLATIN + VINCRISTINE | Y | N | 260022166 | CISPLATIN + ETOPOSIDE |
| 260010122 | 260018901 | 1.81 | 96 | Adjuvant (A) | 2018-03-20 | 2018-03-22 | Cisplatin + Etoposide (3 day) | 2 | N | 260022166 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260010123 | 260006391 | 1.72 | 62 | null | null | 2015-07-20 | 111 Trial (formerly BEP 111) | N | N | 260022492 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010124 | 260006391 | 1.74 | 91 | Curative (C) | 2015-03-31 | 2015-04-01 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 260022492 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260010125 | 260006391 | 1.65 | 118.7 | Palliative (P) | null | 2017-12-22 | Rituximab | null | N | 260022492 | EC |
| 260010126 | 260006392 | 1.63 | 47 | Curative (C) | 2016-08-22 | 2016-09-03 | IVE-R | 02 | N | 260022942 | BENDAMUSTINE |
| 260010127 | 260006392 | null | 64.7 | Curative (C) | 2013-11-18 | 2013-11-29 | Carboplatin + Etoposide IV 3 day | 99 | null | 260022942 | ICE |
| 260010128 | 260006393 | 1.62 | 119 | Disease modification (D) | 2016-02-02 | 2016-02-08 | Rituximab | 02 | N | 260023325 | RITUXIMAB |
| 260010129 | 260012485 | 1.67 | 96.6 | Adjuvant (A) | 2016-04-20 | 2016-04-27 | CISPLATIN + ETOPOSIDE | N | N | 260023349 | IVADO |
| 260010130 | 260015747 | null | 77.8 | Curative (C) | 2015-10-05 | 2015-10-14 | Cisplatin + Etoposide (5 day) | N | null | 260023456 | ETOPOSIDE |
| 260010131 | 260015747 | null | 90.4 | Curative (C) | 2017-10-17 | 2017-10-25 | Cisplatin + Etoposide (5 day) | N | N | 260023456 | CISPLATIN + ETOPOSIDE |
| 260010132 | 260015747 | 1.76 | 86 | Curative (C) | 2018-06-28 | 2018-07-21 | Carboplatin + Etoposide IV 3 day | N | N | 260023456 | CISPLATIN + ETOPOSIDE |
| 260010133 | 260015747 | 1.9 | 75 | Curative (C) | 2016-07-05 | 2016-07-25 | Cisplatin + Etoposide (5 day) | N | N | 260023456 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260010134 | 260006394 | 1.73 | 73.3 | null | 2017-08-12 | 2017-08-13 | TIP | 02 | N | 260024324 | CISPLATIN + ETOPOSIDE |
| 260010135 | 260006395 | null | 79.1 | null | 2016-08-14 | 2016-08-21 | Cisplatin + Vinorelbine (IV) | N | N | 260024424 | CARBOPLATIN + ETOPOSIDE |
| 260010136 | 260012486 | null | null | null | null | 2016-10-04 | Cisplatin + Etoposide (5 day) | null | null | 260025101 | CISPLATIN + ETOPOSIDE |
| 260010137 | 260012486 | 1.67 | 90.6 | Palliative (P) | 2018-09-07 | 2018-09-07 | Bendamustine +/- Prednisolone | 2 | null | 260025101 | RITUXIMAB |
| 260010138 | 260012486 | 1.75 | 109 | Disease modification (D) | 2013-12-11 | 2013-12-17 | Cisplatin + Etoposide (3 day) | 01 | N | 260025101 | CISPLATIN + ETOPOSIDE |
| 260010139 | 260012486 | 1.56 | 73.8 | Disease modification (D) | 2017-05-24 | 2017-06-22 | CARBOPLATIN + PACLITAXEL | N | N | 260025101 | CARBOPLATIN + PACLITAXEL |
| 260010140 | 260006396 | 1.73 | null | Curative (C) | 2017-11-01 | 2017-11-06 | EP | 02 | N | 260025486 | TIP |